Radioligand Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Indication (Prostate Cancer, Neuroendocrine Tumor, Others), By Product (Lutathera, Zytiga, Xtandi, Xofigo), By Biomarker (Prostate-Specific Membrane Antigen, Ki 67 Expression and Grading, Cytochrome P450 17A1 Inhibitor), By End User (Biotechnology & Pharmaceutical Companies, Academic
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationRadioligand Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Indication (Prostate Cancer, Neuroendocrine Tumor, Others), By Product (Lutathera, Zytiga, Xtandi, Xofigo), By Biomarker (Prostate-Specific Membrane Antigen, Ki 67 Expression and Grading, Cytochrome P450 17A1 Inhibitor), By End User (Biotechnology & Pharmaceutical Companies, Academic
The global radioligand therapy market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rising incidence of various types of cancers and increasing awareness of alpha radioimmunotherapy are propelling the growth of the market. Radioligand therapy is an advanced approach to treat certain kinds of cancer. It provides radiation to targeted cancer cells, with a negligible effect on healthy cells.
Rising Incidence of Various types of Cancers
Increased Awareness of Alpha Radioimmunotherapy and Rise in R&D activities
Increasing Investments and rising Initiatives by Government
For instance, in 2021, the European Commission launched Europe’s Beating Cancer Plan which amis to offer cancer services, with focus on disease prevention and early diagnosis. Later, in 2022, the European government has intended to pour over $4.2 billion into cancer research and care.
Market Segmentation
In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising cases of prostate cancer in the country.
Market Players
Novartis International, AG, Johnson & Johnson, Pfizer, Inc., Amneal Pharmaceuticals LLC., POINT Biopharma Global Inc, Fusion Pharmaceuticals Inc., Clovis Oncology, Inc., Telix Pharmaceuticals Limited, Lantheus Holdings, Inc., Progenics Pharmaceuticals, and Bayer AG
| Attribute | Details |
| Base Year | 2021 |
| Historic Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends |
| Segments covered | · Indication · Product · Biomarker · End User · Company |
| Regional scope | North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa |
| Key companies profiled | Novartis International, AG, Johnson & Johnson, Pfizer, Inc., Amneal Pharmaceuticals LLC., POINT Biopharma Global Inc, Fusion Pharmaceuticals Inc., Clovis Oncology, Inc., Telix Pharmaceuticals Limited, Lantheus Holdings, Inc., Progenics Pharmaceuticals, and Bayer AG |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy